Exceed Orphan
  • Company
    • About
    • Team
    • Your Pharma Partner in Europe
  • Solution
    • Market access coordination
    • Marketing and sales
    • Market research and analysis
    • Medical and pre-marketing activities
    • Regulatory, PV and Distribution
  • News
  • Contact
  • Sign in
  • Sign out
Exceed Orphan

Experts for Orphan Drugs
in Central & Eastern Europe

  • Exceed Orphan
  • Solution
    • Market access coordination
    • Market research and analysis
    • Medical and pre-marketing activities
    • Marketing and sales
    • Regulatory, PV and Distribution
  • News
    • #genetherapy
    • #cooperation
    • #news
  • Company
    • About
    • Team
  • Contact

Tag: genetherapy

#blog #cooperation #genetherapy #news
All news
November 20, 2020
  • #cooperation
  • #genetherapy
  • #news

ExCEEd Orphan continues cooperation with Novartis Gene Therapies for Zolgensma®

ExCEEd Orphan will continue next year in cooperation with Novartis Gene Therapies (previously

Read more
May 19, 2020
  • #genetherapy
  • #news

AveXis receives EC approval for Zolgensma®

AveXis receives EC approval and activates “Day One” access program for Zolgensma®, the

Read more
May 15, 2020
  • #genetherapy
  • #news

First SMA Patient in Czechia was treated with gene therapy in Faculty Hospital in Motol

Little Max is the first patient with spinal muscular atrophy who received systemic

Read more
May 6, 2020
  • #genetherapy
  • #news

Gene Therapy reimbursed for SMA patients in Czechia

Czech Health Insurance companies recently approved reimbursement of breakthrough gene therapy treatment for

Read more
March 27, 2020
  • #genetherapy
  • #news

AveXis receives positive CHMP opinion for Zolgensma®

AveXis receives positive CHMP opinion for Zolgensma®, the only gene therapy for spinal

Read more
March 20, 2020
  • #genetherapy
  • #news

Novartis receives approval from Japanese Ministry of Health, Labour and Welfare for Zolgensma®

Novartis receives approval from Japanese Ministry of Health, Labour and Welfare for Zolgensma®

Read more
ExceedOrphan - logo - greyscale
  • Solution
    • Solution
  • Resources
    • Partners area
    • News
  • Company
    • About
    • Team
  • Contact
    • Contact
  • Partners
    • Sign in

© 2020 ExCEEd Orphan

  • GDPR
  • Code of ethics